Page 83 - Contract Development News Today

Continues to strengthen the global chemistry and manufacturing capabilities and capacitiesBEIJING--(BUSINESS WIRE)--Pharmaron Beijing Co., Limited (Stock Code: 300759.SZ/3759.HK) (“Pharmaron”) announced today that it has acquired Aesica Pharmaceuticals Limited (“The Cramlington Site”) from Recipharm group.The Cramli...

The US FDA amended the EUA for Moderna’s Covid-19 vaccine to reduce the time between the initial vaccine and a booster to five months.

A PIONEERING company which is set to develop a state-of-the-art biopharma plant in the UK today welcomed latest moves to ensure Ulverston becomes a…

A PIONEERING company which is set to develop a state-of-the-art biopharma plant in the UK today welcomed latest moves to ensure Ulverston becomes a…

/PRNewswire/ -- Piramal Pharma Limiteds Pharma Solutions (PPS) business, a leading Contract Research, Development and Manufacturing Organization (CDMO), today...

- Multi-million dollar investment augments in-vitro biology capabilities in primary and secondary screening - Brings added value to customers by coupling biology services with existing

/PRNewswire/ -- Piramal Pharma Limiteds Pharma Solutions (PPS) business, a leading Contract Research, Development and Manufacturing Organization (CDMO), today...

Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Market Size, Trends, Shares, Growth, Industry Analysis and Forecast to 2028

Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Market Size, Trends, Shares, Growth, Industry Analysis and Forecast to 2028

ULVERSTON may no longer be the site of a £350m biomanufacturing plant which was set to create hundreds of jobs.